Literature DB >> 21914840

Hippocampal dysfunction in Gulf War veterans: investigation with ASL perfusion MR imaging and physostigmine challenge.

Xiufeng Li1, Jeffrey S Spence, David M Buhner, John Hart, C Munro Cullum, Melanie M Biggs, Andrea L Hester, Timothy N Odegard, Patrick S Carmack, Richard W Briggs, Robert W Haley.   

Abstract

PURPOSE: To determine, with arterial spin labeling (ASL) perfusion magnetic resonance (MR) imaging and physostigmine challenge, if abnormal hippocampal blood flow in ill Gulf War veterans persists 11 years after initial testing with single photon emission computed tomography and nearly 20 years after the 1991 Gulf War.
MATERIALS AND METHODS: The local institutional review board approved this HIPAA-compliant study. Veterans were screened for contraindications and gave written informed consent before the study. In a semiblinded retrospective protocol, veterans in three Gulf War illness groups-syndrome 1 (impaired cognition), syndrome 2 (confusion-ataxia), and syndrome 3 (central neuropathic pain)-and a control group received intravenous infusions of saline in an initial session and physostigmine in a second session, 48 hours later. Each infusion was followed by measurement of hippocampal regional cerebral blood flow (rCBF) with pulsed ASL. A mixed-effects linear model adjusted for age was used to test for differences in rCBF after the cholinergic challenge across the four groups.
RESULTS: Physostigmine significantly decreased hippocampal rCBF in control subjects (P < .0005) and veterans with syndrome 1 (P < .05) but significantly increased hippocampal rCBF in veterans with syndrome 2 (P < .005) and veterans with syndrome 3 (P < .002). The abnormal increase in rCBF was found to have progressed to the left hippocampus of the veterans with syndrome 2 and to both hippocampi of the veterans with syndrome 3.
CONCLUSION: Chronic hippocampal perfusion dysfunction persists or worsens in veterans with certain Gulf War syndromes. ASL MR imaging examination of hippocampal rCBF in a cholinergic challenge experiment may be useful as a diagnostic test for this condition. © RSNA, 2011.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21914840      PMCID: PMC3176422          DOI: 10.1148/radiol.11101715

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  35 in total

1.  Gulf War syndrome: proposed causes.

Authors:  S D Frost
Journal:  Cleve Clin J Med       Date:  2000-01       Impact factor: 2.321

2.  Pediatric perfusion imaging using pulsed arterial spin labeling.

Authors:  Jiongjiong Wang; Daniel J Licht; Geon-Ho Jahng; Chia-Shang Liu; Joan T Rubin; John Haselgrove; Robert A Zimmerman; John A Detre
Journal:  J Magn Reson Imaging       Date:  2003-10       Impact factor: 4.813

3.  Blunted circadian variation in autonomic regulation of sinus node function in veterans with Gulf War syndrome.

Authors:  Robert W Haley; Wanpen Vongpatanasin; Gil I Wolfe; Wilson W Bryan; Roseanne Armitage; Robert F Hoffmann; Frederick Petty; Timothy S Callahan; Elizabeth Charuvastra; William E Shell; W Wesley Marshall; Ronald G Victor
Journal:  Am J Med       Date:  2004-10-01       Impact factor: 4.965

4.  Abnormal brain response to cholinergic challenge in chronic encephalopathy from the 1991 Gulf War.

Authors:  Robert W Haley; Jeffrey S Spence; Patrick S Carmack; Richard F Gunst; William R Schucany; Frederick Petty; Michael D Devous; Frederick J Bonte; Madhukar H Trivedi
Journal:  Psychiatry Res       Date:  2009-02-20       Impact factor: 3.222

5.  Cerebral blood flow changes in benign aging and cerebrovascular disease.

Authors:  T G Shaw; K F Mortel; J S Meyer; R L Rogers; J Hardenberg; M M Cutaia
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

6.  Perfusion deficit to cholinergic challenge in veterans with Gulf War Illness.

Authors:  Peiying Liu; Sina Aslan; Xiufeng Li; David M Buhner; Jeffrey S Spence; Richard W Briggs; Robert W Haley; Hanzhang Lu
Journal:  Neurotoxicology       Date:  2010-12-13       Impact factor: 4.294

7.  Microtubule-associated targets in chlorpyrifos oxon hippocampal neurotoxicity.

Authors:  M A Prendergast; R L Self; K J Smith; L Ghayoumi; M M Mullins; T R Butler; J J Buccafusco; D A Gearhart; A V Terry
Journal:  Neuroscience       Date:  2007-02-22       Impact factor: 3.590

8.  Regional cerebral blood flow and oxygen consumption in human aging.

Authors:  P Pantano; J C Baron; P Lebrun-Grandié; N Duquesnoy; M G Bousser; D Comar
Journal:  Stroke       Date:  1984 Jul-Aug       Impact factor: 7.914

9.  Hippocampal dysfunction in Gulf War Syndrome. A proton MR spectroscopy study.

Authors:  P Mohanakrishnan Menon; Henry A Nasrallah; Roy R Reeves; Jeffrey A Ali
Journal:  Brain Res       Date:  2004-05-29       Impact factor: 3.252

10.  Neurotoxicity resulting from coexposure to pyridostigmine bromide, deet, and permethrin: implications of Gulf War chemical exposures.

Authors:  M B Abou-Donia; K R Wilmarth; K F Jensen; F W Oehme; T L Kurt
Journal:  J Toxicol Environ Health       Date:  1996-05
View more
  20 in total

1.  Mood and memory deficits in a model of Gulf War illness are linked with reduced neurogenesis, partial neuron loss, and mild inflammation in the hippocampus.

Authors:  Vipan K Parihar; Bharathi Hattiangady; Bing Shuai; Ashok K Shetty
Journal:  Neuropsychopharmacology       Date:  2013-06-28       Impact factor: 7.853

Review 2.  Severe life stress and oxidative stress in the brain: from animal models to human pathology.

Authors:  Stefania Schiavone; Vincent Jaquet; Luigia Trabace; Karl-Heinz Krause
Journal:  Antioxid Redox Signal       Date:  2012-08-06       Impact factor: 8.401

3.  Theoretical and experimental evaluation of multi-band EPI for high-resolution whole brain pCASL Imaging.

Authors:  Xiufeng Li; Dingxin Wang; Edward J Auerbach; Steen Moeller; Kamil Ugurbil; Gregory J Metzger
Journal:  Neuroimage       Date:  2014-10-23       Impact factor: 6.556

4.  Event-related potential patterns associated with hyperarousal in Gulf War illness syndrome groups.

Authors:  Gail D Tillman; Clifford S Calley; Timothy A Green; Virginia I Buhl; Melanie M Biggs; Jeffrey S Spence; Richard W Briggs; Robert W Haley; John Hart; Michael A Kraut
Journal:  Neurotoxicology       Date:  2012-06-09       Impact factor: 4.294

5.  FMRI reveals abnormal central processing of sensory and pain stimuli in ill Gulf War veterans.

Authors:  Kaundinya Gopinath; Parina Gandhi; Aman Goyal; Lei Jiang; Yan Fang; Luo Ouyang; Sandeepkumar Ganji; David Buhner; Wendy Ringe; Jeffrey Spence; Melanie Biggs; Richard Briggs; Robert Haley
Journal:  Neurotoxicology       Date:  2012-02-04       Impact factor: 4.294

6.  Central Executive Dysfunction and Deferred Prefrontal Processing in Veterans with Gulf War Illness.

Authors:  Nicholas A Hubbard; Joanna L Hutchison; Michael A Motes; Ehsan Shokri-Kojori; Ilana J Bennett; Ryan M Brigante; Robert W Haley; Bart Rypma
Journal:  Clin Psychol Sci       Date:  2014-05-01

7.  Effects of low-level sarin and cyclosarin exposure on hippocampal subfields in Gulf War Veterans.

Authors:  Linda L Chao; Stephen Kriger; Shannon Buckley; Peter Ng; Susanne G Mueller
Journal:  Neurotoxicology       Date:  2014-07-21       Impact factor: 4.294

8.  Curcumin treatment leads to better cognitive and mood function in a model of Gulf War Illness with enhanced neurogenesis, and alleviation of inflammation and mitochondrial dysfunction in the hippocampus.

Authors:  M Kodali; B Hattiangady; G A Shetty; A Bates; B Shuai; A K Shetty
Journal:  Brain Behav Immun       Date:  2018-02-15       Impact factor: 7.217

Review 9.  Gulf War Illness: Mechanisms Underlying Brain Dysfunction and Promising Therapeutic Strategies.

Authors:  Brandon Dickey; Leelavathi N Madhu; Ashok K Shetty
Journal:  Pharmacol Ther       Date:  2020-10-24       Impact factor: 12.310

10.  Vagus Nerve Stimulation Ameliorates Cognitive Impairment and Increased Hippocampal Astrocytes in a Mouse Model of Gulf War Illness.

Authors:  Lavanya Venkatasamy; Damir Nizamutdinov; Jaclyn Jenkins; Lee A Shapiro
Journal:  Neurosci Insights       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.